What is the appropriate emergency management for an acute hyaluronic‑acid filler‑related vascular occlusion in the chin that is causing mottling of the nose?

Emergency Management of Hyaluronic Acid Filler-Induced Vascular Occlusion with Distant Ischemia

Inject high-dose hyaluronidase immediately—1500 IU into and around the chin injection site, repeated every 15–20 minutes until nasal mottling resolves—because intervention within the first 4–6 hours reverses early-stage ischemia in up to 80% of cases. 1

Immediate Recognition and Triage

This presentation represents arterial embolization with retrograde flow, where hyaluronic acid injected into the chin has traveled proximally through anastomotic vessels to occlude the nasal arterial supply. The mottling pattern indicates impending skin necrosis in a vascular territory distant from the injection site. 1, 2

• Pain is the most reliable early warning sign of vascular occlusion, often preceding visible skin changes by minutes to hours. 1
• Skin color changes progress rapidly: initial blanching or mottling → dusky purple → black necrosis if untreated. 1, 3
• The 4–6 hour window is critical—tissue ischemia becomes irreversible after this period, with permanent necrosis and scarring. 1, 3

First-Line Treatment: Hyaluronidase Protocol

Dosing Strategy

• Start with 1500 IU hyaluronidase injected directly into the chin (original injection site) and into any areas showing mottling or color change on the nose. 1, 4
• Repeat the full 1500 IU dose every 15–20 minutes for at least 4 pulses within the first 24 hours, or until complete resolution of skin color changes. 1, 2
• Do not use low doses—emergent vascular occlusion requires aggressive, high-dose pulsed hyaluronidase, not the 50–150 IU doses used for aesthetic corrections. 4

Injection Technique

• Inject hyaluronidase along the entire affected vascular territory, not just at the original filler site—this means treating both the chin and the nose. 1, 2
• Ultrasound guidance reduces the required hyaluronidase dose by up to tenfold by enabling precise intra-arterial or peri-arterial placement, but do not delay treatment to obtain ultrasound if it is not immediately available. 1, 5
• Fan-pattern injection into the dermis and subcutaneous tissue ensures hyaluronidase reaches all occluded vessels. 4

Adjunctive Pharmacologic Therapy

Antiplatelet Agents (Start Immediately)

• Aspirin 300 mg orally (loading dose) followed by 75–100 mg daily mitigates hyaluronic acid-induced platelet aggregation, which contributes to vascular occlusion. 1
• Clopidogrel 300 mg loading dose followed by 75 mg daily provides additional antiplatelet coverage. 1

Vasodilators (After Initial Hyaluronidase)

• Nitroglycerin paste 2% applied topically to the affected areas improves microvascular perfusion after hyaluronidase has dissolved the hyaluronic acid bolus. 1
• Oral pentoxifylline 400 mg three times daily enhances red blood cell deformability and tissue oxygenation. 1
• Do not use vasodilators as first-line therapy—they are reserved for post-resolution perfusion improvement, not acute occlusion. 1

Corticosteroids (Control Inflammation)

• Methylprednisolone 40–60 mg orally or IV reduces the inflammatory response to ischemia and hyaluronic acid. 1
• Continue corticosteroids for 3–5 days to prevent secondary inflammatory injury. 1

Hyperbaric Oxygen Therapy

• Refer for hyperbaric oxygen (2.0–2.5 ATA for 90 minutes, twice daily) if available within 24 hours—this enhances tissue oxygenation and supports ischemic recovery. 1

Critical Pitfalls to Avoid

• Do not wait for skin necrosis to develop before treating—mottling alone is an absolute indication for immediate high-dose hyaluronidase. 1, 3
• Do not stop after one or two hyaluronidase injections—the pulsed protocol (every 15–20 minutes for 4+ doses) is essential for complete reversal. 1, 2
• Do not confuse this with simple aesthetic overcorrection—distant ischemia (chin injection causing nasal mottling) indicates arterial embolization and requires emergency doses, not cosmetic correction doses. 4, 2
• Do not delay treatment to perform allergy testing—the risk of anaphylaxis to hyaluronidase is far lower than the certainty of permanent necrosis if treatment is delayed. 4
• Do not rely on warm compresses or massage alone—these adjuncts do not dissolve hyaluronic acid and will not reverse arterial occlusion. 1

Monitoring and Escalation

• Reassess skin color every 15 minutes during the first 2 hours—improvement (return of pink color, capillary refill) indicates successful treatment. 1, 3
• If no improvement after 4 pulses of hyaluronidase within 2 hours, consider ultrasound-guided intra-arterial hyaluronidase injection by an interventional radiologist or vascular surgeon. 5
• Admit for observation if skin changes persist beyond 6 hours—these patients require continuous monitoring and may develop delayed necrosis despite treatment. 3
• Photograph the affected areas every 30 minutes to document progression or resolution. 1

Prognosis

• Complete resolution is achievable in 80% of cases when treatment begins within 4–6 hours of symptom onset. 1
• Delayed treatment (>24 hours) results in permanent scarring in the majority of cases, even with aggressive hyaluronidase therapy. 3
• The patient who self-discharged and returned 3 days later with worsening symptoms developed permanent facial scarring, illustrating the critical importance of immediate, sustained treatment. 3